Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone. uri icon

authors

  • Choi, Edward Man-Lik
  • Manno, Daniela
  • D'Ortenzio, Eric
  • Ishola, David
  • Keita, Cheick Mohamed
  • Keshinro, Babajide
  • Njie, Yusupha
  • van Dijck, Wim
  • Gaddah, Auguste
  • Anumendem, Dickson
  • Lowe, Brett
  • Lacarra, Boris
  • Vatrinet, Renaud
  • Lawal, Bolarinde Joseph
  • Otieno, Godfrey T
  • Samai, Mohamed
  • Deen, Gibrilla Fadlu
  • Swaray, Ibrahim Bob
  • Kamara, Abu Bakarr
  • Kamara, Michael Morlai
  • Diagne, Mame Aminata
  • Kowuor, Dickens
  • Afolabi, Muhammed O
  • McLean, Chelsea
  • Leigh, Bailah
  • Beavogui, Abdoul Habib
  • Leyssen, Maarten
  • Luhn, Kerstin
  • Robinson, Cynthia
  • Douoguih, Macaya
  • Greenwood, Brian
  • Thiébaut, Rodolphe
  • Watson-Jones, Deborah
  • Ale, Boni Maxime
  • Baiden, Frank
  • Bétard, Christine
  • Foster, Julie
  • Hamzé, Benjamin
  • Schwimmer, Christine

publication date

  • November 2023